Vialed Saline Placebo, ALXN2030
ALXN2030-AMR-201
Phase 2 small_molecule active
Quick answer
Vialed Saline Placebo, ALXN2030 for Antibody-Mediated Rejection after Kidney Transplantation is a Phase 2 program (small_molecule) at Alexion Europe SAS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alexion Europe SAS
- Indication
- Antibody-Mediated Rejection after Kidney Transplantation
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active